Loading stock data…
Loading stock data…
US$2.15
Get one email when AYTU crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.46%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bullish momentumMACD above its signal line (-0.01).
50-day average
2.22
Price belowShort-term trend reference.
200-day average
2.37
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc. is a specialty pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases, including major depressive disorder (MDD) and attention deficit hyperactivity disorder (ADHD), to improve patient quality of life. Its prescription portfolio features EXXUA (gepirone) extended-release tablets, the first and only FDA-approved selective serotonin 5HT1a receptor agonist for treating MDD in adults, alongside an ADHD portfolio with pro…
aytubio.com2 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
2 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-06-01)
2 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-05-01)
2 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-13 | -0.42 | -0.41 | ✓ Beat |
| 2026-04-28 | 4.82 | 4.97 | ✓ Beat |
| 2026-02-03 | -0.49 | -0.23 | ✓ Beat |
| 2026-01-15 | 2.98 | 3.14 | ✓ Beat |
| 2025-11-13 | -0.19 | -0.09 | ✓ Beat |
| 2025-09-23 | -0.06 | -0.08 | ✗ Miss |
| 2025-05-14 | -0.17 | 0.21 | ✓ Beat |
Companies in the same industry, via Finnhub